VAQTA - 0006-4841-41 - (hepatitis A vaccine, inactivated)

Alphabetical Index


Drug Information of VAQTA

Product NDC: 0006-4841
Proprietary Name: VAQTA
Non Proprietary Name: hepatitis A vaccine, inactivated
Active Ingredient(s): 50    [iU]/mL & nbsp;   hepatitis A vaccine, inactivated
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of VAQTA

Product NDC: 0006-4841
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: VACCINE
FDA Application Number: BLA103606
Marketing Category: BLA
Start Marketing Date: 19960329

Package Information of VAQTA

Package NDC: 0006-4841-41
Package Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4841-41) > 1 mL in 1 VIAL, SINGLE-DOSE (0006-4841-01)

NDC Information of VAQTA

NDC Code 0006-4841-41
Proprietary Name VAQTA
Package Description 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4841-41) > 1 mL in 1 VIAL, SINGLE-DOSE (0006-4841-01)
Product NDC 0006-4841
Product Type Name VACCINE
Non Proprietary Name hepatitis A vaccine, inactivated
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR
Start Marketing Date 19960329
Marketing Category Name BLA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)
Strength Number 50
Strength Unit [iU]/mL
Pharmaceutical Classes Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of VAQTA


General Information